News for Sonoma Pharmaceuticals Inc (O8Z3.MU)

Published at

Mar 2, 2021 5:48 PM

by globalbankingandfinance.com

neutral

neutral

Keloid Treatment Market Forecast to 2027 – COVID-19 Impact and Global Analysis By treatment type and End User, and Geography

According to the latest market report published by FMI titled ‘Keloid Treatment Market: Global Industry Analysis (2012-2016) and Opportunity Assessment

SNOA O8Z3.MU O8Z3.F O8Z3.BE NVSN.MX NVSEF NVSD.BA NVS NOVN.SW NOTA.MU NOTA.F NOTA.BE

Read more →
Published at

Feb 15, 2021 9:45 PM

by benzinga.com

positive

positive

BREAKING ALERT: ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Sonoma Pharmaceuticals, Inc. Investors with Losses to Inquire About Securities Class Action Investigation – SNOA

NEW YORK, Feb. 15, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on ...

SNOA O8Z3.MU O8Z3.F O8Z3.BE

Read more →
Published at

Jan 19, 2021 12:00 AM

by prnewswire.com

neutral

neutral

ROSEN, GLOBAL INVESTOR COUNSEL, Continues To Investigate Securities Claims Against Sonoma Pharmaceuticals, Inc. - SNOA

/PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Sonoma...

SNOA O8Z3.MU O8Z3.F O8Z3.BE

Read more →
Published at

Jan 11, 2021 11:31 PM

by marketscreener.com

positive

positive

Sonoma Pharmaceuticals : to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference

Sonoma Pharmaceuticals, Inc. , a global healthcare leader developing and producing stabilized hypochlorous acid products for a wide range of applications, including wound, eye, oral and nasal care,... | January 11, 2021

SNOA O8Z3.MU O8Z3.F O8Z3.BE

Read more →

News for Sonoma Pharmaceuticals Inc (O8Z3.MU)

Keloid Treatment Market Forecast to 2027 – COVID-19 Impact and Global Analysis By treatment type and End User, and Geography

BREAKING ALERT: ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Sonoma Pharmaceuticals, Inc. Investors with Losses to Inquire About Securities Class Action Investigation – SNOA

ROSEN, GLOBAL INVESTOR COUNSEL, Continues To Investigate Securities Claims Against Sonoma Pharmaceuticals, Inc. - SNOA

Sonoma Pharmaceuticals : to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference